                                                                                                                   
                                                   UNITED STATES                                                   
                                                                                                                   
                                                                                                                   
                                        SECURITIES AND EXCHANGE COMMISSION                                         
                                                                                                                   
                                                                                                                   
                                               Washington, DC 20549                                                
                                                                                                                   
                                                                                                                   
                                                     FORM 8-K                                                      
                                                                                                                   
                                                                                                                   
                                                  CURRENT REPORT                                                   
                                                                                                                   
                                                                                                                   
                                      Pursuant to Section 13 or 15(d) of The                                       
                                                                                                                   
                                                                                                                   
                                          Securities Exchange Act of 1934                                          
                                                                                                                   
                                 Date of report (Date of earliest event reported):                                 
                                                                                                                   
                                                  April 24, 2025                                                   
                                                                                                                   
                                                                                                                   
                                                 Johnson & Johnson                                                 
                                                                                                                   
                              (Exact name of registrant as specified in its charter)                               
                                                                                 
  New Jersey                      1-3215                     22-1024240          
  (State or Other Jurisdiction    -Commission File Number    -IRS Employer       
  of Incorporation)                                          Identification No.  
                                                                                 
                           One Johnson & Johnson Plaza, New Brunswick, New Jersey 08933                            
                                                                                                                   
                                     (Address of Principal Executive Offices)                                      
                                                                                                                   
                                                    (Zip Code)                                                     
                                                                                                                   
                                Registrant's telephone number, including area code:                                
                                                                                                                   
                                                   732- 524-0400                                                   
                                                                                                                   
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation
of the registrant under any of the following provisions:
                                                                                                               
  ☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)                   
  ☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)                  
  ☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  
  ☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))  
                                                                                                               
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the
Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2
of this chapter).
                                
  Emerging growth company    ☐  
                                
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended
transition period for complying with any new or revised financial accounting standards provided pursuant to Section
13(a) of the Exchange Act. ☐
                            SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT                             
                                                                                                    
  Title of each class               Trading Symbol(s)    Name of each exchange on which registered  
  Common Stock, Par Value $1.00     JNJ                  New York Stock Exchange                    
  1.150% Notes Due November 2028    JNJ28                New York Stock Exchange                    
  2.700% Notes due February 2029    JNJ29B               New York Stock Exchange                    
  3.200% Notes Due June 2032        JNJ32                New York Stock Exchange                    
  3.050% Notes due February 2033    JNJ33B               New York Stock Exchange                    
  1.650% Notes Due May 2035         JNJ35                New York Stock Exchange                    
  3.350% Notes Due June 2036        JNJ36A               New York Stock Exchange                    
  3.350% Notes due February 2037    JNJ37B               New York Stock Exchange                    
  3.550% Notes Due June 2044        JNJ44                New York Stock Exchange                    
  3.600% Notes due February 2045    JNJ45                New York Stock Exchange                    
  3.700% Notes due February 2055    JNJ55                New York Stock Exchange                    
                                                                                                    
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers.

D. Adamczyk notified the Company that he intends to retire from the Company’s Board of Directors in connection with
an announcement on April 23 rd that he will join Goldman Sachs as a Partner. The retirement will be effective May
31, 2025. His retirement is for personal reasons and not as a result of any disagreement with management on any
matter relating to the Company’s operations, policies, or practices.

Item 5.07 Submission of Matters to a Vote of Security Holders.

(a) T he 2025 Annual Meeting of Shareholders of the Company was held on April 24, 2025.

(b) At the 2025 Annual Meeting of Shareholders, the shareholders:

• elected all 11 Director nominees named in the 2025 Proxy Statement to the Company ’ s Board of Directors;

• approved, on an advisory basis, the executive compensation philosophy, policies and procedures described in the
“Compensation Discussion and Analysis” section of the 2025 Proxy Statement and the compensation of the Company’s
executive officers named in the 2025 Proxy Statement, as disclosed therein;

• ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting
firm for the fiscal year 2025;

• did not approve the shareholder proposal for shareholder opportunity to vote on excessive golden parachutes; and

• did not approve the shareholder proposal to produce a human rights impact assessment.

The following are the final voting results for each of the five items voted on at the meeting.

1. Election of Directors:
                                                                                        
                         Shares For    Shares Against    Shares Abstain      Non-Votes  
  D. Adamczyk         1,614,881,433        89,638,598         4,656,459    323,923,987  
  M. C. Beckerle      1,663,840,474        41,888,480         3,447,536    323,923,987  
  J. A. Doudna        1,666,450,029        39,271,173         3,455,288    323,923,987  
  J. Duato            1,575,244,633       130,077,890         3,853,967    323,923,987  
  M. A. Hewson        1,654,870,638        50,832,331         3,473,521    323,923,987  
  P. A. Johnson       1,667,900,558        37,823,371         3,452,561    323,923,987  
  H. Joly             1,650,666,053        54,388,932         4,121,505    323,923,987  
  M. B. McClellan     1,662,883,658        42,458,697         3,834,135    323,923,987  
  M. A. Weinberger    1,630,170,833        74,418,349         4,587,308    323,923,987  
  N. Y. West          1,660,661,956        45,083,907         3,430,627    323,923,987  
  E. A. Woods         1,635,362,502        69,986,075         3,827,913    323,923,987  
                                                                                        
2. Advisory vote to approve named executive officer compensation (Say on Pay):
                                                            
  For                  Against    Abstained      Non-Votes  
  1,559,332,581    142,483,900    7,360,009    323,923,987  
                                                            
3. Ratification of appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public
accounting firm for 2025 :
                                                          
  For                  Against    Abstained    Non-Votes  
  1,888,169,154    140,927,885    4,003,438            0  
                                                          
4. Shareholder Proposal - shareholder opportunity to vote on excessive golden parachutes:
                                                           
  For                 Against    Abstained      Non-Votes  
  92,601,525    1,609,744,641    6,830,324    323,923,987  
                                                           
5. Shareholder Proposal - produce a human rights impact assessment:
                                                             
  For                  Against     Abstained      Non-Votes  
  188,350,832    1,498,659,169    22,166,489    323,923,987  
                                                             
                                                                                                                   
  Item 9.01 Financial statements and exhibits                                                                      
                                                                                                                   
(d) Exhibits.
                                                                                                 
  Exhibit No.    Description of Exhibit                                                          
  104            The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.  
                                                                                                 
                                                    Signatures                                                     
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly authorized.

Date: April 30, 2025
                              
         JOHNSON & JOHNSON    
         -Registrant          
  By:    /s/Marc Larkins      
         Marc Larkins         
         Corporate Secretary  
                              
